[Use of carbochromen in coronary insufficiency].
D000136:Acid-Base Equilibrium / Q000187:drug effects*; D000328:Adult; D000787:Angina Pectoris / Q000188:drug therapy*; D001769:Blood / Q000187:drug effects*; D001775:Blood Circulation / Q000187:drug effects; D001777:Blood Coagulation / Q000187:drug effects; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D003864:Depression, Chemical; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D010146:Pain / Q000188:drug therapy; D011188:Potassium / Q000097:blood*; D012964:Sodium / Q000097:blood*; D013268:Stimulation, Chemical; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use
D006454:Hemoglobins; D014665:Vasodilator Agents; D012964:Sodium; D011188:Potassium; D010100:Oxygen
Die Anwendung von Carbochromen bei der Coronarinsuffizienz.